Survival outcomes with trastuzumab deruxtecan in HER2-positive vs. HER2-low breast cancer patients with brain metastases: a real-world cohort study. - Podder V; Sarfraz Z; Ranjan T; McCracken A; Hurmiz C; Hodgson L; Maharaj A; Mahtani R; Ahluwalia MS (Scientific reports, 2026)